JPRN-UMIN000032113招募中未知
Desensitization with rituximab for preformed anti-donor antibody and antibody-mediated rejection in kidney transplantation. - Desensitization with rituximab for preformed anti-donor antibody and antibody-mediated rejection in kidney transplantation.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 10years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •active infection
研究者
相似试验
招募中
不适用
The effect of rituximab in desensitization of preoperative DSA positive patients and postoperative ABMR treatment of DSA positive patients in kidney transplantatioChronic renal failureJPRN-UMIN000035338iigata University10
招募中
不适用
A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly HLA-sensitized Transplant Patients.JPRN-UMIN000011914Transplantation Surgery, Hiroshima University Hospital30
已完成
3 期
Clinical study of Rituximab for inhibition of antibody mediated rejection in ABO-incompatible kidney transplantatioChronic kidney disease patient to whom ABO incompatibility kidney transplantation is planned.JPRN-UMIN000006635Zenyaku Kogyo Co., Ltd.23
进行中（未招募）
1 期
Will a single dose of Rituximab treatment, when taken with anti thyroid drugs for 1 year, stop the over-activity of the thyroid gland from returning once you stop ATD treatment?EUCTR2016-000209-35-GBewcastle upon Tyne Hospitals NHS Foundation Trust27
招募中
不适用
Clinical trial of Rituximab for desensitization or antibody mediated rejection therapy in anti-donor HLA antibody positive patientsChronic renal dysfunction or post kidney transplant recipientsJPRN-jRCTs031180323Saito Kazuhide20